Navigation Links
Epstein-Barr: a virtual look at a vexing virus
Date:10/22/2007

BOSTON (October 22, 2007) Researchers at Tufts University School of Medicine in collaboration with the Virginia Bioinformatics Institute at Virginia Tech have created a computer program called Pathogen Simulation (PathSim) to study the progression of Epstein-Barr virus (EBV) in humans. David Thorley-Lawson, PhD, professor of pathology at Tufts University School of Medicine, is combining PathSim, laboratory methods, and clinical studies to provide a new and powerful approach to understanding EBV and ultimately designing anti-viral therapies.

PathSim is an agent-based computer program. The agents are the virus itself, and the T and B cells of the patients immune system, explains Thorley-Lawson. Using PathSim, Thorley-Lawson can manipulate these agents to simulate EBV infection and persistence in humans. EBV can infect one person and remain latent not cause any symptoms. It can infect another person and cause infectious mononucleosis, or, in rare cases, cancer, like Hodgkins, Burkitts, and immunoblastic lymphomas, says Thorley-Lawson.

Scientists can use PathSim like a video game and change variables, such as number of virus particles or characteristics of the patients immune cells, to follow the course of disease and observe what drives the virus to either latency or illness.

We validated PathSim by comparing it to EBV infection in patients, says Thorley-Lawson. For example, PathSim projected that the peak in the number of infected immune cells, called B cells, would occur 33 through 38 days post-infection, which is consistent with the peak of 35 through 50 days actually seen in infected patients. This consistency is important because it validates the predictive power of PathSim; the power to reveal what EBV is doing in a patients body, says Thorley-Lawson.

It takes one full week to run one simulation, says Thorley-Lawson. Then we compile the data and look for critical switch points of disease. A switch point is a small change in the behavior of an agent that can influence the progression of disease. Such a change may determine whether the virus persists in the body in a latent state, or causes illness and even death by replicating out of control. Once these critical switch points are understood, biologists may be able to develop drugs that target specific points in the interaction between the virus and immune system at specific times, explains Thorley-Lawson. The more targeted the drug, the more safe and effective the resulting therapy. We hope that this marriage of computers and biology will eventually lead to better patient treatment against EBV.


'/>"/>

Contact: Siobhan Gallagher
siobhan.gallagher@tufts.edu
617-636-6586
Tufts University, Health Sciences
Source:Eurekalert

Related medicine news :

1. New virtual colonoscopy procedure for easier colon screening
2. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
3. Virtual Colonoscopy May Be Better Than Real-time Colonoscopy
4. Virtual Reality For Treating Stress Disorders
5. Hip Replacement Can Now Be Performed On Virtual Patients
6. Virtual Reality Simulation Could Help In Training Surgeons
7. New Studies Show The Efficacies Of Virtual Realities Vis-à-vis Pai
8. Virtual Meeting Place Unites Patients with Brain Tumors and Neurosurgical Disorders
9. Virtual Colonoscopy in Colorectal Cancer Prevention and Screening
10. The Tech Savvy Patient Knocks on the Doors of Telemedicine and Virtual Clinics
11. Virtual Colonoscopy is Most-effective for Screening Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... , ... PIXACORE , an independent full-service agency with a decade of ... the year by MM&M. , This is the first time PIXACORE has made the ... agency. PIXACORE’s newfound recognition reflects its steady trajectory of growth and recent strategic ...
(Date:8/21/2017)... ... ... The Industrial Designers Society of America (IDSA) hosted the ... Aug. 19, 2017 in Atlanta, GA—revealing which 25 designs won Gold and which 52 ... See all the winners at http://www.idsa.org/awards/idea/gallery . , “I hope you’re as excited ...
(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult with gluten ... so, you may be interested in participating in a research study that focuses on ... to understand more about the relational aspects of adults who have gluten sensitivities who ...
(Date:8/19/2017)... ... August 18, 2017 , ... President Donald Trump signed into ... provides for greater public access to over-the-counter (OTC) hearing aids. , The measure ... aids without being seen by a certified and licensed audiologist. , “The ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the United States retracted ... sides. There are not two sides to hatred, bigotry, discrimination, and a white supremacy ... the NPEIV stands against all forms of such hatred and discrimination in this country ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017 AccuGenomics, Inc., a diagnostic ... today announced that the company has provided an AccuKit ... North Carolina at Chapel Hill and to Qura Therapeutics ... characterize and quantify HIV reservoir and viral expression in ... The HIV Cure Center is a joint initiative between ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/10/2017)... -- Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation clinic, ... . The reputable clinic will continue to be co-owned and ... staff of four clinicians. Lipkin received his doctorate in physical ... years of experience with a strong background in manual therapy. ... 10th PRN clinic in and around the Denver ...
Breaking Medicine Technology: